U.S. markets closed

Chr. Hansen Holding A/S (CHR.CO)

Copenhagen - Copenhagen Real Time Price. Currency in DKK
Add to watchlist
574.20+5.00 (+0.88%)
At close: 4:59PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close569.20
Open571.00
Bid573.40 x 0
Ask573.40 x 0
Day's Range571.00 - 580.60
52 Week Range504.00 - 734.00
Volume368,551
Avg. Volume295,780
Market Cap75.585B
Beta (5Y Monthly)0.08
PE Ratio (TTM)44.11
EPS (TTM)13.02
Earnings DateJul 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 18, 2021
1y Target Est600.95
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Extraordinary dividend
      GlobeNewswire

      Extraordinary dividend

      Company announcement No. 7 Extraordinary dividend of 6.54 DKK per share to be paid on May 20, 2021 Today, the Board of Directors of Chr. Hansen Holding A/S has decided to declare an extraordinary dividend of EUR 116 million, or 6.54 DKK per share with an ex-dividend date of May 18, 2021. The dividend will be paid on May 20, 2021. The extraordinary dividend follows the completion of the divestment of Natural Colors to EQT and is equivalent to a normalized ordinary dividend for 2019/20, and consistent with the decision by the Annual General Meeting in November 2020 to not pay out an ordinary dividend at the time. For further information please contact:Anders Mohr Christensen, Head of Investor Relations, Tel: +45 2515 2364Annika Stern, Senior Investor Relations Officer, Tel: +45 2399 2382Yannick Vanderveeren, Head of Media Relations, Tel: +45 2068 6425 About Chr. HansenChr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable food ingredients company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do. Attachment No. 7 Extraordinary dividend

    • Chr. Hansen Holding A/S Interim report Q2 2020/21
      GlobeNewswire

      Chr. Hansen Holding A/S Interim report Q2 2020/21

      Continued strong organic growth momentum leads to upwards narrowing of full-year organic growth guidance Q2 2020/21 organic sales growth was 10%, equally split between volume/mix and price, and driven by Health & Nutrition which delivered 14% growth while Food Cultures & Enzymes delivered 8% growthUnderlying EBIT margin b.s.i.1) of 30.9%, incl. >1%-point negative currency impact, compared to 32.2% in Q2 2019/20. Reported EBIT margin b.s.i. (incl. all acquisition impacts) was 27.0%Integration of commercial activities in UAS/HSO is completed and integration of manufacturing is progressingHMO capacity expansion in Germany on track, while delays in product registrations and regulatory approvals remain a constraint on market development; the market opportunity long-term is unchangedFull-year outlook for organic growth adjusted to 6-8% (previously 5-8%), free cash flow narrowed upwards to EUR 140-160 mio, EBIT margin guidance unchanged, and impacts from acquisitions also unchanged from Q1 CEO Mauricio Graber says: “In our second quarter we delivered strong organic growth on a more demanding comparable from last year, with continued good momentum in both business areas. Our business in Asia-Pacific delivered 10% organic growthfueled by Health & Nutrition, providing reassurance that we can grow the region strongly even as the Chinese yogurt market is still in decline. Customer engagement, both in China and globally, remains high despite the current difficulties of in person interactions. Through the acquisitions we have done, we are building a more balanced business globally between Food Cultures & Enzymes and Health & Nutrition. We’ve continued the integration of the acquired businesses and have recently completed a major milestone in the divestment of Natural Colors, and we are executing our strategy of becoming a focused bioscience company based on a unique microbial and fermentation technology platform. Following the divestment of Natural Colors, we have initiated the process for paying out an extraordinary dividend of around EUR 116 million, and payment of the dividend is expected to be effected during the month of May. In Q2 we progressed on our innovation agenda with many new patents, trademarks and registrations, and in Q3 we will be launching the next generation of bioprotection for fermented milks and certain cheeses. As a result of the strong organic growth in the first half of 2020/21, and despite the uncertainties lingering from COVID-19, we have narrowed upwards our full-year outlook for organic growth, and we expect that Q4 to be the stronger of the two remaining quarters, primarily as Q3 of last year had a tailwind effect from customers building COVID-19 related safety inventories.” Outlook for 2020/21Organic revenue growth 6-8%EBIT margin before special items 27-28%Free cash flow before special items, acquisitions and divestments EUR 140-160 millionFor further information, please contact:Martin Riise, Head of IR+45 53 39 22 50Annika Stern, Senior IR Officer+45 23 99 23 82About Chr. HansenChr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable food ingredients company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do. Attachment Chr. Hansen Interim Report Q2 2020_21

    • Natural Colors transaction closed
      GlobeNewswire

      Natural Colors transaction closed

      Divestment of Natural Colors to EQT closed as of March 31, 2021 Chr. Hansen Holding A/S and EQT today announced the completion of the transaction announced on September 26, 2020, whereby EQT and Chr. Hansen Holding A/S entered into an agreement with the purpose of EQT to acquire the Natural Colors division from Chr. Hansen Holding A/S. The divestment follows the 2025 Strategy of Chr. Hansen becoming a differentiated bioscience company with focus on the microbial and fermentation technology platforms. The total consideration for the transaction is EUR 800 million on a cash and debt free basis which Chr. Hansen has already received. Transfer of business activities is completed, however, the full legal transition in a few countries will be finalized during the coming months. Financial implications The proceeds from the divestment will be used to reduce the leverage of Chr. Hansen. Also, as announced in connection with the Annual General Meeting on November 25, 2020, Chr. Hansen intends to pay out an extraordinary dividend at least equal to a normalized ordinary dividend for 2019/20, and will initiate the standard process for paying out extraordinary dividends. More information on the timing of the extraordinary dividend can be expected in connection with the Q2 announcement on April 15, 2021. The one-off profits from the transaction, which is the difference between the book value of the transferred assets and liabilities and the transaction value received, will be accounted for as part of the profits from discontinued operations in Q3. The impact is estimated to be around EUR 650 million after taxes and transaction costs associated with the divestment. The divestment covers business operations with asset transfers in more than 30 countries including transfer of 5 separate corporate entities and around 600 employees. Consistent with the transaction agreement, Chr. Hansen undertakes to provide various transition services for a period of up to two years to Natural Colors/EQT to ensure continuity of Natural Color business activities. The costs associated with Chr. Hansen corporate activities in Natural Colors that are not transferred to EQT will be partly covered by the fees from the transition services agreements, and will not impact the guidance on EBIT margin b.s.i. for this year. Attachment No. 5 Closing of Natural Colors transaction